ADULT ACUTE MINIMALLY DIFFERENTIATED MYELOID LEUKEMIA (M0)

Clinical trials for ADULT ACUTE MINIMALLY DIFFERENTIATED MYELOID LEUKEMIA (M0) explained in plain language.

Never miss a new study

Get alerted when new ADULT ACUTE MINIMALLY DIFFERENTIATED MYELOID LEUKEMIA (M0) trials appear

Sign up with your email to follow new studies for ADULT ACUTE MINIMALLY DIFFERENTIATED MYELOID LEUKEMIA (M0), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Can a Platelet-Boosting drug speed recovery for older leukemia patients?

Disease control Completed

This phase II trial investigates whether eltrombopag, a drug that stimulates platelet production, can help older adults with acute myeloid leukemia (AML) recover their platelet counts faster after initial chemotherapy. Older patients often experience slow platelet recovery, which…

Matched conditions: ADULT ACUTE MINIMALLY DIFFERENTIATED MYELOID LEUKEMIA (M0)

Phase: PHASE2 • Sponsor: Case Comprehensive Cancer Center • Aim: Disease control

Last updated Jul 19, 2026 00:00 UTC

ADULT ACUTE MINIMALLY DIFFERENTIATED MYELOID LEUKEMIA (M0)

Get alerted when new ADULT ACUTE MINIMALLY DIFFERENTIATED MYELOID LEUKEMIA (M0) trials appear

Can a Platelet-Boosting drug speed recovery for older leukemia patients?